Synectics Share Price (SNX)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Synectics	LSE:SNX	London	Ordinary Share	GB0007156838	ORD 20P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	+0.00p	+0.00%	207.50p	200.00p	215.00p	207.50p	207.50p	207.50p	348	07:53:55

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Support Services	70.9	2.0	9.0	23.1	36.92

Related Shares
Experian (EXPN), Worldpay (WPG), PHSC Plc (PHSC), Alpha Returns (ARGP)

Synectics (SNX) Latest News

Synectics News

Date	Time	Source	Headline
18/7/2017	11:18	ALNC	Synectics Posts First Interim Dividend In Four Years As Profit Grows
18/7/2017	07:51	ALNCF	Alliance News Flash Headline
18/7/2017	07:00	UKREG	Synectics PLC Interim Results
06/7/2017	07:00	UKREG	Synectics PLC Notification of Interim Results
06/6/2017	17:54	UKREG	Synectics PLC Re-appointment of Auditor
26/5/2017	10:04	UKREG	Synectics PLC Director/PDMR Shareholding
28/4/2017	16:01	UKREG	Synectics PLC Director/PDMR Shareholding
27/4/2017	14:06	ALNC	Synectics Wins USD1.0 Million Contract, On Track For Full-Year Targets
27/4/2017	13:08	UKREG	Synectics PLC Result of AGM
27/4/2017	07:00	UKREG	Synectics PLC AGM Statement

More Synectics News

Synectics Takeover Rumours

Synectics (SNX) Share Charts

1 Year Synectics Chart

1 Month Synectics Chart

Intraday Synectics Chart

Synectics (SNX) Discussions and Chat

Synectics Forums and Chat

Date	Time	Title	Posts
18/8/2017	11:52	SYNECTICS	309
17/7/2012	16:12	Synexus - One To Watch	127

Add a New Thread

Synectics (SNX) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
07:04:36	200.00	348	696.00	O
2017-08-22 11:33:04	198.00	10,000	19,800.00	OK

View all Synectics trades in real-time

Synectics (SNX) Top Chat Posts

Date	Subject
23/8/2017 09:20	Synectics Daily Update: Synectics is listed in the Support Services sector of the London Stock Exchange with ticker SNX. The last closing price for Synectics was 207.50p. Synectics has a 4 week average price of 205p and a 12 week average price of 197.50p. The 1 year high share price is 250p while the 1 year low share price is currently 177.50p. There are currently 17,790,724 shares in issue and the average daily traded volume is 7,345 shares. The market capitalisation of Synectics is £36,915,752.30. Read Full Thread Reply
02/8/2015 08:59	kombimatec: A steady increase in share price. Great to see, will it continue? Read Full Thread Follow Reply
29/7/2014 11:46	davebowler: Westhouse; Buy SNX.L / 342.5p / £60.95m / TP: 550p Event: Results issued Likely % change in earnings forecasts: No Change Interim results much better second half expected It is encouraging that Synectics expects a strong performance going forward after trading in the six months to end May 2014 proved even more difficult than had initially been anticipated. We make no changes to any of our adj. PBT forecasts implying £5m of adj. PBT in H2 2014 and making the uplift to £9.0m for FY2015 achievable in our view. With a strong order book and sales pipeline we believe that the share price will improve as confidence in hitting our forecasts increases. We maintain our 550p target price and Buy rating. Read Full Thread Follow Reply
26/2/2014 19:04	grahamg8: All good and well. But Westhouse seem to like what they have and raised the target price from 545 to 675. So it's all a bit of a conundrum. Revenue up, profits up, margins up, divi up on the one hand but cash down, order book down on the other; and share price tanked. Read Full Thread Follow Reply
26/2/2014 12:46	dasv: copy and pasted from that link which can be found by googling... Bit of a harsh valuation imo (re likely earnings 2015) and doesn't take into consideration the benefits of re-structuring and positioning for higher value projects. but I'd agree on some/most of the points below. --- Synectics (LON:SNX) This is a CCTV group that I've been following for years, since the days when it was called Quadnetics, a rather nice name I thought, so it seemed a backward step changing it to the difficult to pronounce Synectics. Their final results for the year ended 30 Nov 2013 are out today. Whilst the results look OK, the outlook and reduced order book are a concern. The order book was £28.1m at 30 Nov 2013 (2012: £36.9m), which is a material drop of nearly 24%. So the next step is to look for what the current order book is, to see if it has risen in the last (nearly) three months, so I am skim reading the narrative to locate that. The Chairman's statement gives a pointer; ...We expect the current year to be focused on consolidating these significant organisation and infrastructure investments. Therefore the Board expects results for the current financial year to be at a similar level to 2013. Further details are set out in the Outlook section below. Unfortunately, the outlook section dodges the issue of what the order book is currently standing at, so I can only assume that there has not been any improvement. If there had, then the company would have mentioned it, surely? They say; Delays are continuing to some extent, but bid activity for large projects in the oil & gas and gaming sectors remains solid, and an increased pace of sales is anticipated from several new products being launched in the second quarter of 2014... ...The pattern of our current order pipeline suggests that trading will be significantly skewed towards the second half. Oh dear, there is the dreaded H2-weighted results expected comment. That's not good, as it means a heightened risk of a profit warning if they do not recoup what looks like a gap in the order book. The market has clearly cottoned on to this, and the shares opened down about 20-30p, but have in the last few minutes really nose-dived down 105p to 435p. Ouch. Nothing to do with me, as I haven't published anything yet, am just about to hit the publish button now. So this morning's pretty savage market reaction to Synectics wobbly-sounding outlook is a reminder that when shares are priced to perfection, there isn't any scope for disappointment. That's why I am saying no to so many shares which I consider over-priced at the moment - it's all about risk/reward. If you are being asked to pay up-front for good performance over the next year or two, then you have little upside gains to be made, yet you have all the downside risk if something goes wrong. That's just a lousy investment proposition. What I look for is assymetrical risk/reward the other way around - i.e. where a share is priced with expectations of poor performance, yet there are early signs of them doing well. In that situation you buy at a price where disappointment is already factored in, so you get the upside profit opportunity thrown in for free. Back to Synectics, it delivered strong underlying diluted EPS of 32.6p for 2013, up 29% on prior year. So if we take the optimistic view, and assume they will deliver the same EPS for 2014, then at the current share price (they've bounced a little to 450p) that puts them on a PER of 13.8. Not exactly a massive bargain, considering that's probably the top end of likely performance for 2014. Also, by my calculations they are inflating the underlying EPS figure by stripping out amortisation of capitalised development spend, which is not on in my book. So personally I'd feel more comfortable valuing it on the diluted basic EPS of 29.4p, and putting that on a PER of about 10-11, due to the risk of another profit warning. Note from the cashflow statement that under investing activities, £1m of development costs was capitalised. It's always worth checking for this, as those are cash costs that have by-passed the P&L, hence increasing adjusted profit (which excludes the amortisation charge) by that amount. On the positive side of things, Synectics passes my Balance Sheet testing, and had net cash of just over £1m at 30 Nov 2013. The total year's dividends are up from 7.5p to 8.5p, so at today's reduced 450p level that gives a dividend yield of 1.9%, which is nothing to get excited about, but better than nothing. Remember that this type of business is lumpy, as it's project driven, and as far as I'm aware there isn't much in the way of recurring revenue. That makes it higher risk, and shouldn't be on a high PER, unless it has developed some blockbuster product that will drive rapid growth. I'm not aware of that here, so suggest that the rating should be modest. Something like a PER of say 10-12 is about the right price in my view for this type of business. Therefore I think a price in the 300p ballpark is the sort of level that would get me interested. Even after this morning's drop, it's 50% above that price, so I'm not interested. Risk/reward is still unattractive at the current price, despite the now 16% fall (it's a moving target!) this morning, in my opinion. Remember that sentiment drives share prices in the short term, but its cashflow & dividends that ultimately determine the long term value. I think sentiment is taking a lot of share prices too high at the moment, and that means heavy losses eventually for people who over-pay. Read Full Thread Follow Reply
24/7/2013 09:24	b1ggles: I see nothing wrong with the share price reaction, just a bit of profit-taking after a good run up to the results, it's still higher than it was 2-3 weeks ago. Read Full Thread Follow Reply
24/7/2013 09:03	jamielein: I decided to sell my small holding just to be safe. Don't like the share price reaction and there are other, better things to be in right now. Good Luck to all holders though. I may be back in on future statements. Regards, Jamie Read Full Thread Follow Reply
04/3/2013 20:01	cfro: Actually it was for a £9M contract IC2. Hope the share price carries on up the Kyber tomorrow. :0)) Read Full Thread Follow Reply
04/3/2013 11:25	saucepan: Good to hear, cfro. So is the SNX share price :-) Read Full Thread Follow Reply
01/3/2013 07:40	saucepan: Excellent news. Perhaps that will get the share price moving after excellent results that seem to have fallen under the radar. Read Full Thread Follow Reply
18/10/2012 08:19	davebowler: Westhouse; Strong Buy SNX.L / 272.5p / £47.88m / Likely % change in earnings forecasts: No Change Buying opportunity Synectics' share price has drifted back since the interim results in July while some of the comparator companies have seen their share prices rise. As the focus of investor attention switches to FY2013 in the coming months then we would expect that this share price underperformance will reverse. As has been flagged since it made the Indanet acquisition FY2013 would be the first year of a more meaningful profit contribution. This is reflected in the increase in our forecast PBT to £6.8m (30.4p of EPS) for FY2013 versus the £4.3m (19.1p of EPS) we expect for FY2012. At our 350p target price Synectics now stands at a small P/E discount to the peer group (13.5x vs 14.6x) that we feel is unwarranted hence the reiteration of our Strong Buy recommendation. Read Full Thread Follow Reply

Synectics share price data is direct from the London Stock Exchange

Your Recent History

LSE

GKP

Gulf Keyst..

LSE

QPP

Quindell

FTSE

UKX

FTSE 100

LSE

IOF

Iofina

GBPUSD

UK Sterlin..

Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P:42 V: D:20170823 08:11:21